Bracco initiates MultiHance shipments

Contrast developer Bracco Diagnostics has begun commercial shipments of its MultiHance gadolinium-based MR contrast agent.

The company's president and chief executive officer, Carlo Medici, delivered the first commercial shipment of the product to Dr. Martin Prince of Weill Cornell MRI, who played a key role in the development and research of the product, according to the Princeton, NJ-based firm.

By AuntMinnie.com staff writers
February 8, 2005

Related Reading

Bracco gets FDA nod for MultiHance, November 24, 2004

SonoVue reinstated for echo use, November 1, 2004

Berlex, Bracco, E-Z-EM, PETNet form consortium, September 27, 2004

CHMP recommends SonoVue reinstatement, August 5, 2004

Bracco clarifies SonoVue restrictions, May 24, 2004

Copyright © 2005 AuntMinnie.com

Page 1 of 611
Next Page